Loading...
IQVIA Holdings Inc.
0JDM.L•LSE
Healthcare
Medical - Pharmaceuticals
£158.43
£-1.00(-0.63%)
IQVIA Holdings Inc. (0JDM.L) Financial Performance & Statements
Review IQVIA Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.81%
↑ 2.81%
Operating Income Growth
11.38%
↑ 11.38%
Net Income Growth
1.10%
↑ 1.10%
Operating Cash Flow Growth
26.38%
↑ 26.38%
Operating Margin
13.85%
↑ 13.85%
Gross Margin
34.72%
↑ 34.72%
Net Profit Margin
8.61%
↑ 8.61%
ROE
20.74%
↑ 20.74%
ROIC
10.65%
↑ 10.65%
IQVIA Holdings Inc. (0JDM.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for IQVIA Holdings Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.96B | $3.90B | $3.81B | $3.74B |
| Cost of Revenue | $2.58B | $2.52B | $2.76B | $2.71B |
| Gross Profit | $1.38B | $1.38B | $1.06B | $1.03B |
| Gross Profit Ratio | $0.35 | $0.35 | $0.28 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $453.00M | $522.00M | $509.00M | $508.00M |
| Operating Expenses | $752.00M | $828.00M | $509.00M | $508.00M |
| Total Costs & Expenses | $2.50B | $3.32B | $3.27B | $3.22B |
| Interest Income | $11.00M | $13.00M | $12.00M | $11.00M |
| Interest Expense | $171.00M | $170.00M | $163.00M | $166.00M |
| Depreciation & Amortization | $303.00M | $278.00M | $269.00M | $264.00M |
| EBITDA | $1.02B | $798.00M | $817.00M | $767.00M |
| EBITDA Ratio | $0.26 | $0.20 | $0.21 | $0.21 |
| Operating Income | $626.00M | $550.00M | $548.00M | $524.00M |
| Operating Income Ratio | $0.16 | $0.14 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | -$82.00M | -$201.00M | -$84.00M | -$166.00M |
| Income Before Tax | $544.00M | $349.00M | $436.00M | $340.00M |
| Income Before Tax Ratio | $0.14 | $0.09 | $0.11 | $0.09 |
| Income Tax Expense | $112.00M | $65.00M | $75.00M | $49.00M |
| Net Income | $437.00M | $285.00M | $363.00M | $288.00M |
| Net Income Ratio | $0.11 | $0.07 | $0.10 | $0.08 |
| EPS | $2.44 | $1.57 | $1.99 | $1.58 |
| Diluted EPS | $2.42 | $1.55 | $1.97 | $1.56 |
| Weighted Avg Shares Outstanding | $178.90M | $182.10M | $182.20M | $181.90M |
| Weighted Avg Shares Outstanding (Diluted) | $180.80M | $184.20M | $184.30M | $184.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan